Complete guide to vkorc1 warfarin dosing genetics. Learn about genetic mechanisms, health impact, testing options, and personalized strategies.
7-Mar 2026·28 min read
Pharmacogenetics
How your DNA affects drug metabolism and medication response. Explore genes like CYP2D6, CYP2C19, SLCO1B1, DPYD, and TPMT that determine how your body processes medications.
20 articles
Pharmacogenetics is the study of how your genetic makeup influences the way your body metabolizes medications. Every person carries a unique set of enzyme variants — particularly in the cytochrome P450 family — that can make a drug work perfectly, cause dangerous side effects, or render it completely ineffective. Understanding these variants is no longer a luxury reserved for research labs; it is becoming a cornerstone of modern personalized medicine.
At the center of pharmacogenetic testing are genes like CYP2D6 and CYP2C19, which together metabolize roughly 40% of all commonly prescribed drugs, including antidepressants, beta-blockers, opioids, and proton-pump inhibitors. A single nucleotide change in CYP2D6 can turn a patient into a "poor metabolizer," meaning standard doses accumulate to toxic levels, or an "ultra-rapid metabolizer," where the drug is cleared so fast it never reaches therapeutic concentration. Clinical studies have shown that CYP2D6 testing before prescribing codeine can prevent life-threatening respiratory depression, especially in children.
Beyond the CYP family, genes such as DPYD (critical for fluorouracil chemotherapy safety), TPMT (essential for thiopurine dosing in autoimmune diseases and leukemia), and SLCO1B1 (linked to statin-induced muscle damage) play pivotal roles in drug safety. The FDA now includes pharmacogenetic information on the labels of over 300 medications, and leading health systems worldwide are integrating preemptive genetic testing into routine care.
For consumers who have already taken a direct-to-consumer DNA test through services like 23andMe or AncestryDNA, the raw data file contains many of these pharmacogenetic variants. By uploading your genome to Ask My DNA, you can explore your CYP2D6, CYP2C19, DPYD, and VKORC1 status and have an informed conversation with your healthcare provider about whether your current medications are optimally dosed for your unique genetic profile.
Complete guide to slco1b1 statin myopathy genetics. Learn about genetic mechanisms, health impact, testing options, and personalized strategies.
6-Mar 2026·14 min read
Complete guide to cyp3a5 tacrolimus transplant genetics. Learn about genetic mechanisms, health impact, testing options, and personalized strategies.
5-Mar 2026·17 min read
Complete guide to nat2 slow acetylator genetics. Learn about genetic mechanisms, health impact, testing options, and personalized strategies.
4-Mar 2026·30 min read
Complete guide to mdr1 abcb1 drug resistance. Learn about genetic mechanisms, health impact, testing options, and personalized strategies.
3-Mar 2026·31 min read
An honest breakdown of genetic testing: what DNA tests can and cannot tell you, accuracy data, privacy risks, and when testing is actually worth the money.
1-Mar 2026·15 min read
Download your 23andMe raw data and unlock pharmacogenomics, nutrition genetics, and health risk insights. Step-by-step guide with tools and privacy tips.
1-Mar 2026·12 min read
Carrying the HLA-B*57:01 variant creates a 50-60% risk of severe hypersensitivity to abacavir, an HIV antiretroviral medication. This genetic marker makes yo...
20-Feb 2026·6 min read
G6PD deficiency drug reactions occur when individuals with glucose-6-phosphate dehydrogenase deficiency take medications triggering oxidative stress, causing...
19-Feb 2026·12 min read
TPMT azathioprine dosing determines how your body processes immunosuppressant medications like Imuran. Your TPMT gene variants directly affect drug metabolis...
18-Feb 2026·10 min read
DPYD 5-fluorouracil toxicity refers to severe reactions caused by genetic variants in the DPYD gene that impair metabolism of 5-FU chemotherapy drugs. Approx...
17-Feb 2026·17 min read
VKORC1 warfarin dosing genetics determines how your body responds to warfarin, the most prescribed blood thinner worldwide. Genetic variants in the VKORC1 ge...
16-Feb 2026·22 min read
Muscle pain from cholesterol medication isn't just bad luck—it's often written in your DNA. The SLCO1B1 gene controls how your liver processes statins, parti...
15-Feb 2026·28 min read
Your CYP2C19 gene determines how effectively your body converts Plavix (clopidogrel) into its active form—a process that directly impacts your cardiovascular...
14-Feb 2026·21 min read
Complete guide to clopidogrel (Plavix) pharmacogenetics. Learn how CYP2C19 genetic variants affect clopidogrel effectiveness, cardiovascular protection, and alternative medications.
28-Nov 2025·15 min read
Complete guide to antidepressant pharmacogenetics. Learn how CYP2D6 and CYP2C19 genetic variants affect SSRI response, side effects, and medication selection.
26-Nov 2025·27 min read
Complete guide to statin pharmacogenetics. Learn how SLCO1B1 genetic variants affect statin-induced muscle pain, myopathy risk, and cholesterol medication choice.
25-Nov 2025·18 min read
Complete guide to warfarin pharmacogenetics. Learn how CYP2C9 and VKORC1 genetic variants affect warfarin dosing, bleeding risk, and anticoagulation management.
24-Nov 2025·26 min read
Essential CYP2D6 gene guide. Learn how CYP2D6 variants affect metabolism of 25% of medications including antidepressants, pain meds, and more.
29-Oct 2025·19 min read
Learn how pharmacogenetics uses your DNA to predict drug response. Understand CYP genes, medication metabolism, and personalized prescribing.
20-Oct 2025·17 min read